[Intraspinal manifestation of cysticercosis--Cysticercus racemosus. A case report and review of the literature].
Malzacher Vd, E Bogumil-Schott, I S Neu
Abstract
Malzacher Vd, E Bogumil-Schott, I S Neu
Abstract
Neurocysticercosis is one of the most common, world-wide parasitic diseases of the central nervous system. On the basis of a case report and a review of the literature, the present paper describes the rare course of an intraspinal cysticercus racemosus infection. In conjunction with magnetic resonance imaging and computed tomography it is necessary to consider conventional myelography occupies an important position in the diagnosis of spinal manifestations of cysticercosis, cross-reactions, especially with Echinococcus antigens, by means of serological tests. In addition to the desirable surgical removal of the cysts, drug therapy with praziquantel and albendazole may be employed. Albendazole has recently been authorized for use in Germany.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Neurocysticercosis is one of the most common, world-wide parasitic diseases of the central nervous system. On the basis of a case report and a review of the literature, the present paper describes the rare course of an intraspinal cysticercus racemosus infection. In conjunction with magnetic resonance imaging and computed tomography it is necessary to consider conventional myelography occupies an important position in the diagnosis of spinal manifestations of cysticercosis, cross-reactions, especially with Echinococcus antigens, by means of serological tests. In addition to the desirable surgical removal of the cysts, drug therapy with praziquantel and albendazole may be employed. Albendazole has recently been authorized for use in Germany.
Key concepts: Neurocysticercosis, Albendazole, Cysticercosis, Praziquantel, Echinococcus, Myelography, Medicine, Echinococcosis